Drug-labels.com

Odan-Spor-Hc: Uses, Side Effects and Dosage

Updated:
Facts
Status:
Prescription (Rx) Current status: Dormant
Strength:
10000 UNIT / 3.5 MG / 10 MG

Patient Medication Information: uses, side effects, how to take - Odan-Spor-Hc

What is ODAN-SPOR-HC used for?

ODAN-SPOR-HC is used to treat bacterial infections of the auditory canal (ear).

ODAN-SPOR-HC contains antibacterial ingredients called polymyxin B, and neomycin and it should be used exactly as directed by your healthcare professional.

How does ODAN-SPOR-HC work?

ODAN-SPOR-HC contains two types of medicines:

  • Hydrocortisone to reduce inflammation.
  • Antimicrobials to kill bacteria and reduce infections.

What are the ingredients in ODAN-SPOR-HC?

Medicinal ingredients: polymyxin B (as sulfate), neomycin (as sulfate) and hydrocortisone. Non-medicinal ingredients are: Cetyl Alcohol, Polysorbate 80, Propylene Glycol, Purified Water for injection and Thimerosal 0.01% as a preservative.

ODAN-SPOR-HC comes in the following dosage forms:

Sterile plastic dropper bottles of 10 mL.

Do not use ODAN-SPOR-HC if you:

  • you have tuberculous, fungal or viral lesions.
  • are allergic to any of the ingredients in ODAN-SPOR-HC.

To help avoid side effects and ensure proper use, talk to your healthcare professional before you take ODAN-SPOR-HC. Talk about any health conditions or problems you may have, including if you:

  • have a damaged eardrum (tympanic membrane);
  • have asthma or allergies;
  • are pregnant or planning to become pregnant;

  • are breastfeeding or planning to breastfeed.

Tell your healthcare professional about all the medicines you take, including any drugs, vitamins, minerals, natural supplements or alternative medicines.

How to take ODAN-SPOR-HC:

  • You should lie with the affected ear upward and then the drops should be instilled. This position should be maintained for 5 minutes to facilitate penetration of the drops into the ear canal. Repeat, if necessary for the opposite ear.
  • If preferred, a cotton wick may be inserted into the canal and then the cotton may be saturated with the solution. This wick should be kept moist by adding further solution every 4 hours. The wick should be replaced at least once every 24 hours.
  • Avoid touching the dropper with your ear or fingers to prevent contamination.
  • Misuse or overuse of ODAN-SPOR-HC could lead to the growth of bacteria that will not be killed by polymyxin B or neomycin (resistance). This means that ODAN-SPOR-HC or other medicines that contain polymyxin B, or neomycin may not work for you in the future.
  • Do not share your medicine.
  • Do not use for longer than 10 days.

Usual dose:

Adults: Instill 4 drops into the affected ear 3 or 4 times daily.

Infants and Children: 3 drops are suggested because of the small capacity of the ear canal.

Overdose:

If you think you have taken too much ODAN-SPOR-HC, contact your healthcare professional, hospital emergency department or regional poison control centre immediately, even if there are no symptoms.

What are possible side effects from using ODAN-SPOR-HC?

These are not all the possible side effects you may feel when taking ODAN-SPOR-HC. If you experience any side effects not listed here, contact your healthcare professional.

The reaction occurring most often is allergic sensitization. The following local adverse reactions have been reported with topical corticosteroids, especially under occlusive dressings:

  • dryness;
  • sensitivity around hair follicles;
  • excessive hair growth;
  • acne breakouts;
  • bleaching of skin;
  • rash around mouth, eyes or nose;
  • weakening of the skin;
  • secondary infection;
  • thinning of the skin;
  • heat rash.

Serious side effects and what to do about them

Symptom / effectTalk to your healthcare professionalStop taking drug and get immediate medical help
Only if severeIn all cases
Burning, redness, irritation, swelling or pain
✓
Allergic skin reaction
✓

If you have a troublesome symptom or side effect that is not listed here or becomes bad enough to interfere with your daily activities, talk to your healthcare professional.

Reporting Side Effects

You can report any suspected side effects associated with the use of health products to Health Canada by:

Visiting the Web page on Adverse Reaction Reporting (https://www.canada.ca/en/health-canada/services/drugs-health-products/medeffect-canada/adverse-reaction-reporting.html) for information on how to report online, by mail or by fax; or

Calling toll-free at 1-866-234-2345.

NOTE: Contact your health professional if you need information about how to manage your side effects. The Canada Vigilance Program does not provide medical advice.

Storage:

Store between 15 and 30 °C. Keep container tightly closed.

Keep out of reach and sight of children.

If you want more information about ODAN-SPOR-HC:

  • Talk to your healthcare professional
  • Find the full product monograph that is prepared for healthcare professionals and includes this Patient Medication Information by visiting the Health Canada website (https://www.canada.ca/en/health-canada.html ); or by contacting the manufacturer, Odan Laboratories Limited at 1-800-387-9342.

Last Revised: June 5, 2019

About this document

Source: Health Canada – Drug Product Database (DPD) and product monographs · DIN (Drug Identification Number): 00626600

Revision date stated in the text: June 5, 2019

Found a mistake? Write to us via the contact page.

The information on this site does not replace the advice of a doctor or pharmacist.

Drug information for Odan-Spor-Hc

Rx or OTC
Prescription (Rx)?
DIN 00626600
Schedule(s) PRESCRIPTION
Active ingredient(s) Polymyxin b sulfate 10000 UNIT, Neomycin sulfate 3.5 MG, Hydrocortisone 10 MG
Dosage form(s) Suspension
Route(s) of administration Otic
Drug class (WHO ATC)
  1. S Sensory organ drugs
    1. S02 Otologicals
      1. S02C Corticosteroids and antiinfectives in combination, otologic
        1. S02CA Corticosteroids and antiinfectives in combination
          1. S02CA03 Hydrocortisone and antiinfectives
Company ODAN LABORATORIESLTD
Current status Dormant
Current status date June 22, 2017

Source: Health Canada – Drug Product Database (DPD) and product monographs, data as of November 1, 2026. Data from the Health Canada Drug Product Database, as published there. Not a substitute for the advice of a doctor or pharmacist.